Valuation : Stem Cells Spin S.A.

Market Cap	19.51M 5.23M 4.51M 4.23M 3.86M 7.26M 498M 7.31M 50.15M 253M 19.65M 19.23M 836M	P/E 2024	-15.6x	P/E 2025	-31.9x
Enterprise Value	19.6M 5.26M 4.53M 4.25M 3.88M 7.29M 500M 7.34M 50.36M 254M 19.74M 19.31M 840M	EV / Sales 2024	151x	EV / Sales 2025	257x
Free-Float	19.04%	Yield 2024 *	-	Yield 2025	-

* Estimated data More valuation ratios

Latest news : Stem Cells Spin S.A.

08-14	Stem Cells Spin S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
05-15	Stem Cells Spin S.A. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
02-16	Stem Cells Spin S.A. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025	CI
11-14	Stem Cells Spin S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
14/08/25	Stem Cells Spin S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025	CI
13/05/25	Stem Cells Spin S.A. Reports Earnings Results for the First Quarter Ended March 31, 2025	CI
14/02/25	Stem Cells Spin S.A. Reports Earnings Results for the Full Year Ended December 31, 2024	CI
14/02/25	Stem Cells Spin S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2024	CI
14/08/24	Stem Cells Spin S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024	CI
15/05/24	Stem Cells Spin S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
14/02/24	Stem Cells Spin S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	CI
14/02/24	Stem Cells Spin S.A. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	CI
14/11/23	Stem Cells Spin S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI

More news

Managers and Directors : Stem Cells Spin S.A.

Manager	Title	Age	Since
Adam Symber CEO	Chief Executive Officer	45	01/01/2017

Director	Title	Age	Since
Marek Andrzej Cegielski BRD	Director/Board Member	74	28/06/2022
Andrzej Jan Trznadel BRD	Director/Board Member	64	-
Piotr Okoniewski BRD	Director/Board Member	-	15/03/2022

More insiders

Other Biotechnology & Medical Research

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
STEM CELLS SPIN S.A.	+8.16%	+9.50%	+12.77%	+47.22%	5.86M
LONZA GROUP AG	-1.23%	-1.91%	+0.98%	+17.94%	50.47B
REVOLUTION MEDICINES, INC.	-1.11%	-2.84%	+420.04%	+505.15%	44.56B
IQVIA HOLDINGS INC.	-0.21%	+0.37%	+36.88%	+17.32%	43.08B
BEONE MEDICINES AG	-1.95%	-3.33%	+8.29%	+73.25%	41.7B
CELLTRION, INC.	-0.94%	-1.77%	+18.34%	+46.84%	33.21B
MEDPACE HOLDINGS, INC.	-1.11%	-4.20%	+25.49%	+119.78%	16.77B
ASCENDIS PHARMA A/S	+6.10%	+4.40%	-	-	16.28B
EUROFINS SCIENTIFIC SE	+0.25%	-0.98%	+11.91%	+27.62%	14.58B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-1.12%	-3.46%	+76.50%	+39.37%	13.92B
Average	+0.68%	+0.16%	+67.91%	+99.39%	27.46B
Weighted average by Cap.	-0.60%	-1.05%	+88.95%	+122.84%

See all sector performances

Stem Cells Spin SA is a Poland-based company. It is primarily engaged in biotechnology research. The Company is focused on development, production, marketing and sale of natural regenerative products for the dermocosmetic and veterinary care markets.

Employees

Sector

Biotechnology & Medical Research

Calendar

11-16 Earnings release - Q3 2026

More about the company

Quotes

Date	Price	Change	Volume
31/08/26	PLN 0.4720	-10.94%	5
28/08/26	PLN 0.5300	+8.16%	1,927
27/08/26	PLN 0.4900	+4.26%	4,682
26/08/26	PLN 0.4700	+0.43%	5,186
25/08/26	PLN 0.4680	-0.43%	300

End-of-day quote Warsaw S.E.

More quotes

Select your edition

All financial news and data tailored to specific country editions

NORTH AMERICA

United-States

Canada

End-of-day quote Warsaw S.E. 28/08/2026			5-day change	1st Jan Change
0.5300 ^PLN	+8.16%		+9.50%	+30.54%

1 day	+8.16%
1 week	+9.50%
Current month	+8.16%
1 month	+8.61%
3 months	+47.22%
6 months	+32.50%
Current year	+30.54%

1 week	0.47	0.53
1 month	0.4	0.53
Current year	0.33	0.54
1 year	0.28	0.54
3 years	0.14	0.82
5 years	0.14	1.12
10 years	0.14	2.04

	2024	2025
Net sales	54.28K 14.56K 12.54K 11.77K 10.75K 20.19K 1.39M 20.33K 140K 703K 54.68K 53.49K 2.33M	65.74K 17.64K 15.18K 14.26K 13.02K 24.45K 1.68M 24.63K 169K 851K 66.22K 64.78K 2.82M
Net income	-520K -140K -120K -113K -103K -194K -13.28M -195K -1.34M -6.73M -524K -513K -22.3M	-526K -141K -121K -114K -104K -196K -13.42M -197K -1.35M -6.8M -529K -518K -22.53M
Net Debt	69.28K 18.59K 16K 15.03K 13.72K 25.77K 1.77M 25.95K 178K 897K 69.79K 68.28K 2.97M	84.58K 22.69K 19.54K 18.35K 16.75K 31.46K 2.16M 31.69K 217K 1.09M 85.21K 83.36K 3.63M

Stem Cells Spin S.A. Stock

Stocks

SCS

PLSTCLS00013

Biotechnology & Medical Research

Valuation : Stem Cells Spin S.A.

Chart: Stem Cells Spin S.A.

Latest news : Stem Cells Spin S.A.

Quotes and Performance

Price Extremes

Managers and Directors : Stem Cells Spin S.A.

Other Biotechnology & Medical Research

Financials

Company Profile

Quotes